December 11-12, 2013 • The Ritz-Carlton Washington, DC
2014: Crossroads or Turning Point?
Prepare for the next wave of public policy changes that will reshape the
climate for biopharma companies by attending the ninth annual FDA/CMS
Summit for Biopharma Executives. Hear frst-hand from government and
industry experts on these important issues:
• Updates on the new drug review
process and post-marketing
surveillance oversight at FDA
• Provocative discussions of the
next hot topics in regulatory reform
and Medicare coverage
• Top priorities for CMS in 2014
• The latest on health insurance
expansion: Medicaid, the exchanges
• And much, much more
and political dynamics
GLOBAL SPONSORS
GOLD SPONSORS
SILVER SPONSORS
FE ATURED S PEA KER S
REGISTER TODAY
& SAVE!
Early Bird Rate
Expires 11/8/13
Janet Woodcock, MD
Margaret Hamburg, MD
director, Center For drug evaluation Commissioner, Food and drug
& research, Food and drug
administration (Fda)
administration (Fda)
REGISTER TODAY! ➧
ASSOCIATION SPONSORS
MEDIA PARTNERS
www.fdacms-summit.com
For information on Registration and Sponsorship Opportunities, please contact:
KRISTEN MACHOLTZ
Phone: (908) 748-1192 • Email: k.macholtz@elsevier.com
Share the Knowledge:
#FDACMS